UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...

A new analysis shows no clear link between paternal valproate use and harm in offspring, raising questions about the EMA ...

The virus can be fatal in up to 85% of cases, initially causing symptoms such as fever, headaches, pain, vomiting and a sore ...

Nipah is seen by the World Health Organisation as a research priority because of its pandemic potential. The virus is fatal ...

Alfie Ennis suffers from Duchenne muscular dystrophy and is in desperate need of medication to help his condition ...

Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...

A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Abbisko Therapeutics Co., Ltd. (02256.HK) today announced that the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for pimicotinib, a highly selective ...

A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...

Nipah is seen by the World Health Organisation as a research priority because of its pandemic potential. The virus is fatal ...

The Nipah virus is seen by the World Health Organisation as a research priority because of its pandemic potential ...

Scientists have fast-tracked a vaccine for a killer virus with pandemic potential that is fatal in up to 85 per cent of cases ...